SEC Form 4 · accession 0001869579-26-000006
Rani Therapeutics Holdings, Inc. · RANI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Talat Imran
Officer — Chief Executive Officer · Director
Period of report
Dec 27, 2024
Accepted (ET)
Jul 21, 2026 · 6:25 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001856725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F3 | Dec 27, 2024 | S | 8,014 | $1.41 | D | 486,737 | D | |
| Class A Common StockF1,F3 | Jun 27, 2025 | F | 9,076 | $0.55 | D | 477,661 | D | |
| Class A Common StockF1,F3 | Sep 27, 2025 | F | 9,077 | $0.48 | D | 468,584 | D | |
| Class A Common StockF1,F3 | Dec 27, 2025 | F | 7,906 | $1.40 | D | 460,678 | D | |
| Class A Common StockF1,F3 | Mar 22, 2026 | F | 8,916 | $1.13 | D | 451,762 | D | |
| Class A Common StockF1,F3 | Mar 27, 2026 | F | 9,099 | $0.81 | D | 442,663 | D | |
| Class A Common StockF1,F3 | Jun 27, 2026 | F | 7,927 | $0.74 | D | 434,736 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction is being reported late due to inadvertent administrative oversight.
- F2Represents the sale of shares to cover tax withholding obligations in connection with the settlement and release of the restricted stock units.
- F3Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- F4Represents shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations in connection with the settlement and release of the restricted stock units.